FDA Approves Trials for Ecstasy

NowThis 2016-11-30

Views 62

If successful, prescription MDMA will be available by 2021.
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
FDA approves trials for ecstasy to help PTSD patients
play
05:59

FDA approves trials for ecstasy to help PTSD patients
U.S. FDA approves continuation of AstraZeneca's Phase III COVID-19 vaccine trials in the U.S.
play
00:51

U.S. FDA approves continuation of AstraZeneca's Phase III COVID-19 vaccine trials in the U.S.
The FDA Approved Ecstasy Trials as a Treatment for PTSD
play
00:49

The FDA Approved Ecstasy Trials as a Treatment for PTSD
U.S. FDA approves genetically modified salmon for human consumption
play
01:34

U.S. FDA approves genetically modified salmon for human consumption
U.S. FDA approves Moderna's COVID-19 vaccine
play
00:39

U.S. FDA approves Moderna's COVID-19 vaccine
FDA approves Celltrion’s biosimilar drug Remsima for sales in U.S.
play
01:56

FDA approves Celltrion’s biosimilar drug Remsima for sales in U.S.
U.S. FDA approves first antigen test kit for COVID-19
play
00:49

U.S. FDA approves first antigen test kit for COVID-19
U.S. FDA approves Moderna vaccine for emergency use
play
00:37

U.S. FDA approves Moderna vaccine for emergency use
U.S. FDA approves emergency authorization of convalescent plasma to treat COVID-19 patients
play
00:49

U.S. FDA approves emergency authorization of convalescent plasma to treat COVID-19 patients
U.S. FDA approves emergency authorization of convalescent plasma to treat COVID-19 patients
play
01:34

U.S. FDA approves emergency authorization of convalescent plasma to treat COVID-19 patients
FDA approves first over-the-counter birth control pill in U.S. - 1breakingnews.com
play
00:23

FDA approves first over-the-counter birth control pill in U.S. - 1breakingnews.com
FDA approves Celltrion’s biosimilar drug Remsima for sales in U.S.
play
02:28

FDA approves Celltrion’s biosimilar drug Remsima for sales in U.S.